A U.S. bankruptcy judge has approved a $535 million settlement involving defunct talc supplier Whittaker, Clark & Daniels and companies connected to Berkshire Hathaway, rejecting objections from people who allege that asbestos-contaminated talc caused their cancers.
The ruling, issued Thursday, October 22, by U.S. Bankruptcy Judge Michael Kaplan in New Jersey, represents a significant development in a legal dispute involving thousands of personal injury claims and the financial responsibilities of companies connected to the former supplier.
The settlement is intended to resolve certain asbestos-related liabilities involving Berkshire Hathaway’s insurance affiliate National Indemnity Co., chemical distributor Brenntag and other corporate affiliates. However, attorneys representing claimants argued that the agreement undervalues their claims and could protect financially stronger companies from potentially billions of dollars in additional liability.
Claimants’ attorney Suzanne Ratcliffe criticized the decision and said she planned to appeal. The dispute therefore remains part of a broader legal battle over how responsibility for historical asbestos exposure should be allocated when a company has ceased operating and entered bankruptcy.
Why Did the Judge Approve the $535 Million Settlement?
The settlement emerged from the bankruptcy proceedings of Whittaker, Clark & Daniels, a former supplier of talc and industrial compounds that faced a growing number of lawsuits.
Approximately 2,700 people had sued the company, alleging that its talc products contained asbestos and that exposure contributed to serious illnesses, including mesothelioma and other cancers.
Whittaker filed for bankruptcy in 2023 as litigation mounted. The company subsequently negotiated a $535 million agreement involving companies associated with its corporate history.
Judge Kaplan concluded that the settlement was fair and reasonable after considering the claims, the available evidence and the likelihood that claimants could obtain judgments against former corporate parents and affiliates.
The judge also rejected a request by claimants to pursue certain companies directly for additional contributions, ruling that the relevant claims belonged to the bankruptcy estate and were to be pursued by the debtor.
The decision does not mean that every allegation of asbestos-related injury has been individually proven. Instead, it addresses how the disputed liabilities and potential recoveries should be handled through the bankruptcy process.
Who Is Whittaker, Clark & Daniels?
Whittaker, Clark & Daniels was once a major U.S. business involved in processing, manufacturing, storing and distributing talc and other industrial materials.
Its products served a range of industries, including cosmetics and chemical manufacturing. The company became the subject of extensive litigation after claimants alleged that some of the talc it supplied was contaminated with asbestos.
Asbestos is a group of naturally occurring minerals whose microscopic fibers can cause serious diseases when inhaled. Exposure has been associated with mesothelioma, lung cancer and other illnesses, sometimes after a long delay between exposure and diagnosis.
Talc and asbestos can occur in geologically similar environments, creating concerns about contamination when talc is mined or processed. The allegations against Whittaker formed part of a wider wave of litigation involving companies that supplied or used talc in consumer and industrial products.
Whittaker ceased operating in 2004. Although its business operations ended, legal claims related to its historical activities continued to develop over subsequent years.
How Brenntag and Berkshire Hathaway Became Involved
The company’s corporate history is central to understanding the current dispute.
In 2004, Brenntag acquired Whittaker’s operating assets. The transaction excluded certain existing asbestos and environmental liabilities, leaving those obligations with Whittaker.
National Indemnity Co., an insurance company associated with Berkshire Hathaway, later acquired Whittaker’s equity in 2007 and assumed its remaining assets and liabilities.
As asbestos-related lawsuits accumulated, claimants began seeking compensation not only from the defunct supplier but also from companies they argued could bear responsibility through their corporate relationships or earlier transactions.
Brenntag has denied responsibility for Whittaker’s talc liabilities.
The $535 million settlement was developed to resolve claims involving these corporate relationships, including potential successor-liability and contribution claims. Under the agreement, the participating companies receive releases from specified asbestos-related liabilities in exchange for settlement funding.
The arrangement has become controversial because claimants believe the companies involved may have substantially greater financial resources than the defunct supplier itself.
Why Are Cancer Claimants Opposing the Deal?
The main objection concerns whether $535 million is sufficient to compensate current and future claimants.
Attorneys representing the claimants argued that the settlement was negotiated without adequate participation from those who would ultimately depend on the funds. They also characterized it as an insider arrangement that could shield companies with substantial resources from larger claims.
Some claimants have estimated that the potential liabilities could reach approximately $5.3 billion, substantially more than the settlement amount. The companies’ experts have presented much lower estimates of the likely liabilities.
This difference illustrates the central disagreement: how much the claims are potentially worth and how much money could realistically be recovered through further litigation.
For people suffering from serious illnesses, the amount available for compensation can be particularly important because medical expenses, lost income and other financial consequences may continue for years.
Future claimants also raise a difficult question. Some people exposed to asbestos may not develop symptoms or receive a diagnosis until many years later, making it challenging to estimate the eventual number and value of claims.
The judge nevertheless found the settlement reasonable based on the circumstances of the bankruptcy and the prospects for recovery through alternative legal routes.
Why the Bankruptcy Court Rejected Further Direct Lawsuits
Another important aspect of the decision involves who has the legal authority to pursue claims against the companies connected to Whittaker.
Claimants asked for permission to sue Brenntag, National Indemnity and other potential corporate successors directly for additional contributions.
Judge Kaplan denied that request, finding that the relevant claims belonged to Whittaker as the debtor and therefore formed part of its bankruptcy estate.
In bankruptcy proceedings, a debtor’s estate may include certain legal claims that can be pursued for the benefit of creditors. The court’s decision means that individual claimants cannot simply take over those particular claims when the law assigns them to the bankruptcy estate.
The ruling does not establish that every company connected to Whittaker is free from every possible claim. Rather, it addresses the specific legal rights and claims at issue in the bankruptcy proceeding.
The distinction is important because the settlement’s scope and the legal avenues still available to claimants will determine what further compensation may be possible.
Claimants Plan to Challenge the Ruling
Suzanne Ratcliffe, an attorney representing asbestos claimants, condemned the decision and said she planned to appeal.
The claimants have argued that the settlement unfairly limits their ability to pursue companies that they believe could be held responsible for the historical liabilities.
They have also petitioned the U.S. Supreme Court over a broader legal question: whether a company in bankruptcy can use the process to prevent plaintiffs from bringing certain lawsuits against non-bankrupt owners or related companies.
The Supreme Court had not acted on that petition at the time of the latest reporting.
These disputes reflect continuing legal uncertainty surrounding mass-tort bankruptcies, particularly when a company has transferred its operating assets but retains substantial liabilities.
The outcome of any appeal could affect how the settlement is implemented and how similar disputes are handled in future cases.
A Wider History of Talc and Asbestos Litigation
The Whittaker case is part of a much larger wave of litigation involving alleged asbestos contamination in talc products.
For decades, talc was widely used in cosmetics, body powders and other consumer products because of its softness and moisture-absorbing properties. Concerns about possible asbestos contamination have led to lawsuits against suppliers, manufacturers and other businesses throughout the industry.
Some of these cases have resulted in substantial verdicts or settlements, while others have involved disputes over exposure evidence, medical causation and the responsibility of different companies in the supply chain.
Bankruptcy has become one mechanism through which certain companies attempt to resolve large numbers of injury claims. Such proceedings can establish a structured process for distributing available funds, but they also raise concerns about whether claimants receive adequate compensation and whether non-bankrupt businesses should remain exposed to litigation.
The Whittaker dispute adds to that debate by highlighting the tension between obtaining a settlement that provides a defined recovery and preserving the ability to seek potentially larger judgments through further lawsuits.
What Happens Next?
The immediate next step is the legal response to the bankruptcy court’s approval of the agreement.
Claimants’ attorneys have indicated that they intend to challenge the decision. The outcome will depend on the issues raised on appeal and any further rulings by the courts.
The settlement’s approval is an important milestone, but it does not mean that every individual claimant’s compensation has already been paid or that all related litigation has ended.
The agreement is designed to resolve specified liabilities involving the participating companies. Other legal questions, including the rights of claimants and the scope of the releases, will depend on the settlement documents and subsequent court proceedings.
Conclusion
The approval of Whittaker, Clark & Daniels’ $535 million settlement marks a significant development in a long-running dispute involving alleged asbestos-contaminated talc and thousands of people seeking compensation for cancer-related injuries.
The agreement offers a defined financial resolution involving companies connected to the former supplier, including Berkshire Hathaway’s National Indemnity affiliate. However, claimants argue that the amount falls far short of potential liabilities and unfairly restricts their ability to pursue other companies.
With an appeal planned and a related petition pending before the U.S. Supreme Court, the dispute could continue to influence how courts handle corporate responsibility, asbestos claims and mass-tort bankruptcies.
Oliver Johnson is LawScroller’s Senior Legal Correspondent specializing in civil litigation, class actions, and consumer lawsuit coverage. He breaks down complex settlements and court decisions into clear, practical guidance for readers.